LeonaBio (LONA) Shares Outstanding (2019 - 2026)
LeonaBio's (LONA) quarterly Shares Outstanding (Entity) came in at $19.0 million in Q1 2026, up 387.34% year-on-year from $3.9 million in Q1 2025, and up 345.0% on a QoQ basis from $4.3 million in Q4 2025.
LeonaBio (LONA) Shares Outstanding (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Shares Outstanding (Entity) data on file, last reported at $19.0 million in Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 387.34% year-over-year to $19.0 million in Q1 2026; TTM through Mar 2026 was $19.0 million, a 387.34% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, up 9.52% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $19.0 million, up from $4.3 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for LONA reached as high as $19.0 million in Q1 2026 and fell as low as $3.8 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $4.8 million across 5 years, with a median of $3.8 million in 2024.
- Across the five-year window, Shares Outstanding (Entity) gained 0.63% in 2023 and soared 387.34% in 2026, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $3.8 million in 2022, then advanced by 0.78% to $3.8 million in 2023, then gained by 2.27% to $3.9 million in 2024, then climbed by 9.52% to $4.3 million in 2025, then jumped by 345.0% to $19.0 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $19.0 million in Q1 2026, $4.3 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 198.10 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 19.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.03 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.94 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 3.85 Mn |
| Sep 30, 2024 | 3.85 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.83 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 3.81 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 3.77 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 3.77 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 3.73 Mn |
| Jun 30, 2021 | 3.72 Mn |